Kuei-Hua Chang - Publications

Affiliations: 
2012 Purdue University, West Lafayette, IN, United States 

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Chang KH, Vincent F, Shah K. Deregulated Cdk5 triggers aberrant activation of cell cycle kinases and phosphatases inducing neuronal death. Journal of Cell Science. 125: 5124-37. PMID 22899714 DOI: 10.1242/Jcs.108183  0.581
2012 Johnson EO, Chang KH, Ghosh S, Venkatesh C, Giger K, Low PS, Shah K. LIMK2 is a crucial regulator and effector of Aurora-A-kinase-mediated malignancy. Journal of Cell Science. 125: 1204-16. PMID 22492986 DOI: 10.1242/Jcs.092304  0.631
2011 Chi X, Amet T, Byrd D, Chang KH, Shah K, Hu N, Grantham A, Hu S, Duan J, Tao F, Nicol G, Yu Q. Direct effects of HIV-1 Tat on excitability and survival of primary dorsal root ganglion neurons: possible contribution to HIV-1-associated pain. Plos One. 6: e24412. PMID 21912693 DOI: 10.1371/Journal.Pone.0024412  0.406
2011 Kumar D, Kumar NM, Chang KH, Gupta R, Shah K. Synthesis and in-vitro anticancer activity of 3,5-bis(indolyl)-1,2,4-thiadiazoles. Bioorganic & Medicinal Chemistry Letters. 21: 5897-900. PMID 21873049 DOI: 10.1016/J.Bmcl.2011.07.089  0.545
2011 Johnson EO, Chang KH, de Pablo Y, Ghosh S, Mehta R, Badve S, Shah K. PHLDA1 is a crucial negative regulator and effector of Aurora A kinase in breast cancer. Journal of Cell Science. 124: 2711-22. PMID 21807936 DOI: 10.1242/Jcs.084970  0.602
2011 Sun KH, Chang KH, Clawson S, Ghosh S, Mirzaei H, Regnier F, Shah K. Glutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activity. Journal of Neurochemistry. 118: 902-14. PMID 21668448 DOI: 10.1111/J.1471-4159.2011.07343.X  0.595
2011 Kumar D, Patel G, Chavers AK, Chang KH, Shah K. Synthesis of novel 1,2,4-oxadiazoles and analogues as potential anticancer agents. European Journal of Medicinal Chemistry. 46: 3085-92. PMID 21481985 DOI: 10.1016/J.Ejmech.2011.03.031  0.554
2011 Kumar D, Vaddula BR, Chang KH, Shah K. One-pot synthesis and anticancer studies of 2-arylamino-5-aryl-1,3,4-thiadiazoles. Bioorganic & Medicinal Chemistry Letters. 21: 2320-3. PMID 21429743 DOI: 10.1016/J.Bmcl.2011.02.083  0.562
2011 Chang KH, Multani PS, Sun KH, Vincent F, de Pablo Y, Ghosh S, Gupta R, Lee HP, Lee HG, Smith MA, Shah K. Nuclear envelope dispersion triggered by deregulated Cdk5 precedes neuronal death. Molecular Biology of the Cell. 22: 1452-62. PMID 21389115 DOI: 10.1091/Mbc.E10-07-0654  0.575
2011 Kumar D, Narayanam MK, Chang KH, Shah K. Synthesis of novel indolyl-1,2,4-triazoles as potent and selective anticancer agents. Chemical Biology & Drug Design. 77: 182-8. PMID 21251232 DOI: 10.1111/J.1747-0285.2010.01051.X  0.529
2011 Kumar D, Vaddula BR, Chang K, Shah K. ChemInform Abstract: One-Pot Synthesis and Anticancer Studies of 2-Arylamino-5-aryl-1,3,4-thiadiazoles. Cheminform. 42: no-no. DOI: 10.1002/chin.201134131  0.405
2010 Kumar D, Maruthi Kumar N, Chang KH, Shah K. Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazoles. European Journal of Medicinal Chemistry. 45: 4664-8. PMID 20692741 DOI: 10.1016/J.Ejmech.2010.07.023  0.55
2010 Chang KH, de Pablo Y, Lee HP, Lee HG, Smith MA, Shah K. Cdk5 is a major regulator of p38 cascade: relevance to neurotoxicity in Alzheimer's disease. Journal of Neurochemistry. 113: 1221-9. PMID 20345761 DOI: 10.1111/J.1471-4159.2010.06687.X  0.499
Show low-probability matches.